Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Personalized Medicine|December 27, 2024
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective StudyNicoletta Bernardini, Annunziata Dattola, Raimondo Rossi, et al.
BMC Pediatrics|July 2, 2024
Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter studyEmanuele Dilaghi, Enrico Felici, Edith Lahner, et al.
International Journal of Molecular Sciences|September 9, 2022
Is Melanoma Progression Affected by Thyroid Diseases?Salvatore Ulisse, Enke Baldini, Daniele Pironi, et al.
Clinical Endocrinology|June 19, 2012
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free intervalSalvatore Ulisse, Enke Baldini, Salvatore Sorrenti, et al.
Dermatology Practical & Conceptual|August 9, 2024
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio RegionAnnunziata Dattola, Nicoletta Bernardini, Giacomo Caldarola, et al.
Drugs in Context|July 9, 2026
Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio regionFrancesca Feresin, Nicoletta Bernardini, Elena Campione, et al.
Microorganisms|July 2, 2021
May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of LiteratureMichela Ileen Biondo, Chiara Fiorentino, Severino Persechino, et al.
Dermatology Practical & Conceptual|March 30, 2026
Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio RegionAnnunziata Dattola, Francesca Paola Sasso, Giorgio Marotta, et al.
Drugs in Context|September 15, 2025
Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptomsAnnunziata Dattola, Nicoletta Bernardini, Jasmine Anedda, et al.
Dermatology Practical & Conceptual|April 14, 2025
Evaluating the Efficacy of Bimekizumab across the Different Sensitive Areas in Moderate-to-Severe Psoriasis: A 52-week Italian Multicenter Real-Life Lazio ExperienceAnnunziata Dattola, Nicoletta Bernardini, Elena Campione, et al.
Pageof 5